Our commitment

At Vicore, we understand the substantial unmet need for treatment options for patients with rare lung diseases. The burden of fibrotic lung disease is considerable for both patients and their families; we are committed to developing new drugs that are effective and well tolerated to improve the prognosis for patients and increase their quality of life.